Fall 2025
Develops veterinary diagnostics and laboratory services
No salary listed
Sant Cugat del Vallès, Barcelona, Spain
Hybrid
This is a hybrid position allowing for both remote and in-office work.
IDEXX Laboratories, Inc. develops and sells products and services aimed at improving animal health and water quality. Their offerings include in-clinic diagnostic tools, reference laboratory services, and practice management software for veterinarians. These products help veterinarians perform accurate and efficient diagnostics, which can enhance the health outcomes for companion animals, livestock, and poultry. IDEXX stands out from competitors by providing a comprehensive suite of solutions that not only focus on diagnostics but also include software for managing veterinary practices. The company's goal is to support veterinarians in delivering high-quality care while ensuring the health of animals and the safety of water.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Westbrook, Maine
Founded
1983
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Mental Health Support
Pet Insurance
Employee Stock Purchase Plan
Volunteer Paid Days Off
WESTBROOK, Maine, June 5, 2025 /PRNewswire/ - IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst(R) Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and diagnosis and management of Cushing's syndrome in dogs.
February 2022: IDEXX Laboratories launched the Procyte One analyzer in South Korea, leveraging advanced flow cytometry laser technology.
Quantbot Technologies LP makes new $341,000 investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX).
The American College of Veterinary Internal Medicine (ACVIM) has partnered with IDEXX Laboratories, Inc. to endorse the SpringBoard program, offering complimentary, resident-focused educational resources.
Legacy Capital Group California Inc. makes new $750,000 investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX).